CartX Revenue and Competitors
Estimated Revenue & Valuation
- CartX's estimated annual revenue is currently $1.6M per year.
- CartX's estimated revenue per employee is $87,000
Employee Data
- CartX has 18 Employees.
- CartX grew their employee count by 100% last year.
CartX's People
Name | Title | Email/Phone |
---|
CartX Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $57.6M | 318 | 24% | N/A | N/A |
#2 | $44.6M | 286 | 23% | $25.4M | N/A |
#3 | $5.1M | 44 | -6% | N/A | N/A |
#4 | $35.1M | 225 | -3% | $46.9M | N/A |
#5 | $14.5M | 100 | 5% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $1.5M | 17 | 0% | N/A | N/A |
#8 | $2.9M | 29 | -12% | N/A | N/A |
#9 | $125.2M | 691 | 6% | N/A | N/A |
#10 | $95.9M | 529 | -1% | N/A | N/A |
What Is CartX?
CartX's mission is to allow anyone to create a store and start selling online. Anyone can have an online business. We remove infrastructure complexity so you can focus on what you do best: build your brand. Now providing thousands of customers with the highest converting, friction-less, e-commerce experience in Brazil. CartX is the go-to solution to increase sales and order average value.
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.6M
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CartX News
2022-03-22 - Pathogen-specific humoral immunity and infections in BCMA-directed chimeric
antigen receptor T-cell therapy recipients with multiple myeloma
BACKGROUND: Chimeric antigen receptor (CAR) T cells targeting B-cell maturation antigen (BCMA-CARTx) are an emerging treatment for relapsed...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 18 | -40% | N/A |
#2 | $2.4M | 18 | -33% | N/A |
#3 | $1.4M | 18 | -18% | N/A |
#4 | $1.4M | 18 | -10% | $406.5M |
#5 | $1.4M | 18 | -33% | $173M |